User profiles for Stefano Aliberti
Stefano AlibertiHumanitas University, Milan, Italy Verified email at hunimed.eu Cited by 23300 |
[HTML][HTML] Pulmonary fibrosis secondary to COVID-19: a call to arms?
P Spagnolo, E Balestro, S Aliberti… - The Lancet …, 2020 - thelancet.com
As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000 people
have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all COVID-19-…
have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all COVID-19-…
[HTML][HTML] Integrative microbiomics in bronchiectasis exacerbations
Bronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization
and infection. We present an approach to the multi-biome that integrates bacterial, viral …
and infection. We present an approach to the multi-biome that integrates bacterial, viral …
European Respiratory Society guidelines for the management of adult bronchiectasis
…, MJ McDonnell, S Aliberti… - European …, 2017 - Eur Respiratory Soc
Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …
exacerbations in many patients. There have been no previous international guidelines. The …
The bronchiectasis severity index. An international derivation and validation study
JD Chalmers, P Goeminne, S Aliberti… - American journal of …, 2014 - atsjournals.org
Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …
[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
…, A Signori, G Bozzi, F Minoia, S Aliberti… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
Towards tuberculosis elimination: an action framework for low-incidence countries
…, MA Aziz, MRM Al Lawati, S Aliberti… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …
(<100 TB cases per million population) that are striving for TB elimination. The framework …
Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study
…, G Mathis, C Mempel, A Schuler, P Zechner, S Aliberti… - Chest, 2012 - Elsevier
Background The aim of this prospective, multicenter study was to define the accuracy of
lung ultrasound (LUS) in the diagnosis of community-acquired pneumonia (CAP). Methods …
lung ultrasound (LUS) in the diagnosis of community-acquired pneumonia (CAP). Methods …
A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis
…, MJ McDonnell, H Abo-Leyah, S Aliberti… - Annals of the …, 2015 - atsjournals.org
Rationale: Eradication and suppression of Pseudomonas aeruginosa is a key priority in national
guidelines for bronchiectasis and is a major focus of drug development and clinical trials…
guidelines for bronchiectasis and is a major focus of drug development and clinical trials…
Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
To understand how a protective immune response against SARS-CoV-2 develops over time,
we integrated phenotypic, transcriptional, and repertoire analyses on PBMCs from patients …
we integrated phenotypic, transcriptional, and repertoire analyses on PBMCs from patients …
[HTML][HTML] Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
…, D Stolz, C Brightling, T Welte, S Aliberti… - European respiratory …, 2021 - Eur Respiratory Soc
Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …